Supplementary Table 1.

PASI scores of all patients throughout the study.

Patient No.	Group	PASI
		W0	W12	W24
1	P	28.2	22.2	0.4
2	P	27.4	4.2	2.2
3	P	19.8	23.1	1.0
4	P	54.0	54.0	6.9
5	P	15.6	12.8	0.0
6	P	12.2	13.2	0.7
7	P	17.6	33.1	1.6
8	P	28.2	4.8	1.4
9	P	14.6	17.8	6.4
10	P	12.2	9.6	2.7
11	P	21.4	30.2	4.2
12	P	13.2	15.9	0.0
13	P	13.2	28.8	9.8
14	U	23.2	15.8	15.6
15	U	22.9	15.6	3.0
16	U	22.5	6.1	3.3
17	U	20.6	1.6	0.5
18	U	26.0	1.8	9.3
19	U	14.9	4.8	0.0
20	U	34.8	2.4	0.0
21	U	16.2	0.0	0.0
22	U	20.0	0.0	1.4
23	U	24.6	2.3	0.1
24	U	15.4	0.1	0.0

P – placebo; U – ustekinumab. W0 – week 0; W12 – week 12, W24 – week 24.